Cozaar Tablet, Film Coated
Product Images NDC 78206-121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cozaar (NDC 78206-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cozaar 01)

FDA Label Image

Figure 1 (Cozaar 02)

FDA Label Image

Figure 2 (Cozaar 03)

FDA Label Image

Figure 3 (Cozaar 04)

Figure 3 (Cozaar 04)
This table displays the hazard ratio and confidence intervals for primary composite stroke (fatal and non-fatal) comparing treatment with Cozaar and Atenolol. The table is divided into different categories such as age, gender, race, diabetes, and history of cardiovascular disease. The symbols on the table are proportional and represent the sample size. The table is adjusted for Framingham risk score, core, and level of electrocardiography and ventricular hypertrophy.*
FDA Label Image

Figure 4 (Cozaar 05)

Figure 4 (Cozaar 05)
The text appears to be a graph related to medical data which indicates the risk reduction percentage among patients for a certain event. The treatment being tested is "cozam" and it shows a significant difference compared to the placebo group (p=0.022). However, without further context or information it is difficult to determine the exact nature of the findings.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
Cozaar® is a prescription medication formulated in the UK with 25mg of losartan potassium per tablet. It is manufactured by Organon LLC, a subsidiary of Merck & Co., with active ingredients made in France. Each package contains 90 tablets and should be stored in a tightly closed container away from light at a temperature of 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). Further information such as the usual dosage can be found in the package insert. The product is serialized with a barcode, serial number, expiry, and lot number.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Cozaar (Losartan Potassium Tablets) is a product of Organon LLC, a subsidiary of ORGANON & Co., and each tablet contains 50 mg of losartan potassium. The recommended storage temperature is 25°C (77°F) with permissible excursions from 15-30°C (59-86°F) [see USP Controlled Room Temperature]. The product must be kept away from light and the container needs to be tightly closed. The usual dosage is mentioned in the package insert. This package contains 30 tablets represented by NDC 78206-122-01 and the manufacture date, and other details are mentioned in the encoding area.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Cozaar is a prescription medication containing 100 mg of losartan potassium. It is manufactured by Organon and comes in a container of 30 tablets. The tablets should be stored at a temperature between 15-30°C (59-86°F) and protected from light. It is only available by prescription. This document also includes information in a possibly encoded area for serialization, including information such as a 2D barcode, serial number, expiry date, and lot number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.